Welcome to Supply-Chain360, your all-in-one source for actual insights into the world of SCM!

Welcome to Supply-Chain360, your all-in-one source for actual insights into the world of SCM!

Ralph Leyendecker
Country USA
Language EN
Episodes 21
Latest 15.03.2026

This podcast explores the latest innovations, technologies, and strategies transforming the global supply chain landscape. It covers topics from BANI to generative AI, automation, sustainability, and risk management. The show features in-depth discussions, expert interviews, and actionable tips for professionals and enthusiasts alike. Whether you're a supply chain professional or just curious, it provides insights to optimize operations and learn something new.

Episodes

  • Chokepoints After Davos:  What Great-Power Politics Now Means for Real Supply Chains
    Chokepoints After Davos: What Great-Power Politics Now Means for Real Supply Chains 15.03.2026 8m
    In this episode, I follow up on Davos 2026 by shifting from speeches and symbolism to the physical realities of global supply chains. The focus is on chokepoints: the Red Sea, Suez, Hormuz, and Taiwan, and on what happens when great-power politics starts to narrow the corridors, systems, and dependencies that modern industries rely on.I look at how recent developments have moved from rhetoric into operating conditions: fragile reopenings, renewed disruptions, and rising uncertainty around routes, energy, shipping, and trade policy. From a pharma and healthcare perspective, the key point is tha...
  • After Davos: Great-Power Theater, Middle-Power Strategy, and Pharma Supply Chains
    After Davos: Great-Power Theater, Middle-Power Strategy, and Pharma Supply Chains 23.01.2026 17m
    In this episode, I look at Davos 2026 not as a media show, but as a live stress test of the global order.From Merz’ “age of great powers” narrative to Trump’s tariff threats, Greenland remarks, and pressure over U.S. bonds, Davos made one thing clear: the world is being run more openly as a great-power game again, and middle powers, especially in Europe, are caught in the squeeze.I translate this into the language of pharma and healthcare supply chains.We explore how tariffs, sanctions, export controls, dollar dependence, and critical infrastructure decisions (plants, APIs, IT, banks) create s...
  • From Country Crisis to Risk Portfolio – How Pharma Supply Chains should think about Geopolitics
    From Country Crisis to Risk Portfolio – How Pharma Supply Chains should think about Geopolitics 19.01.2026 15m
    In this episode, I move beyond “one crisis at a time” and look at geopolitics through the lens of a risk portfolio for pharma and med-tech supply chains. Starting from recent events like Venezuela, the Red Sea, Taiwan, and Europe’s energy debate, I sketch a simple way to map exposure versus geopolitical fragility – not as a theoretical exercise, but as a practical tool for network and governance decisions.I talk about what leaders can actually control: where buffers sit, how contracts handle sanctions and export controls, how decision rights are set, and which trade lanes are treated as “singl...
  • Venezuela and the BANI World – Implications for Health and Pharma Supply Chains
    Venezuela and the BANI World – Implications for Health and Pharma Supply Chains 05.01.2026 11m
    In this episode, I unpack the recent U.S. military operation that led to Nicolás Maduro’s capture and ongoing narco-terrorism proceedings in New York, and look at what this actually means for health and pharma supply chains in and around Venezuela.Rather than debating the politics, I focus on access to medicines, sanctions and logistics friction, and two working scenarios: a managed transition with selective relief versus a prolonged standoff where Venezuela remains a high-friction, low-priority market. I also explore how spillover effects, migration, shifting demand, and NGO procurement, coul...
  • Holiday Message – Merry Christmas and see you in 2026!
    Holiday Message – Merry Christmas and see you in 2026! 22.12.2025 1m
    This short holiday episode is a quick thank-you from me to you before I step away for a year-end break. I share a few reflections on this past year in pharma supply chains and what’s coming next for the podcast, then hit pause until the new year.Wishing you a Merry Christmas, and a healthy start into the new year. See you soon in the next season of Supply Chain 360.
  • From Signals to Action – SOPs and Response Playbooks in Pharma Disruption
    From Signals to Action – SOPs and Response Playbooks in Pharma Disruption 15.12.2025 9m
    In this episode of Supply Chain 360, we complete the arc from scenarios to signals to action. After building an early-warning radar for your pharma supply chain, the next question is: what happens when a signal actually flashes red?We explore how to turn early warnings into fast, coordinated responses using lean, scenario-specific SOPs – response playbooks. Instead of long policy documents, these mini-SOPs define, on a single page:which triggers matter,what options you have,who owns each action, andwho is empowered to decide, and how quickly.We walk through concrete examples for suppliers and...
  • From Scenarios to Signals – Building an Early-Warning System for Pharma Supply Chains
    From Scenarios to Signals – Building an Early-Warning System for Pharma Supply Chains 08.12.2025 8m
    In this episode of Supply Chain 360, we move one step further along the BANI journey: from imagining possible futures to actually seeing them coming.Building on the previous episode on scenario planning, we explore how pharma organizations can turn scenarios into a practical early-warning system – a simple risk radar that helps you act before disruption fully hits.We look at how to define meaningful signals for your key scenarios: creeping lead times, recurring minor quality issues, lane performance degrading, temperature excursions, regulatory noise, or carrier behavior that hints at capacity...
  • From Gut Feeling to Scenarios – Preparing your Pharma Supply Chain for the Unexpected
    From Gut Feeling to Scenarios – Preparing your Pharma Supply Chain for the Unexpected 01.12.2025 7m
    In this episode of Supply Chain 360, we move from forecasting to future-proofing. Instead of asking “What’s the plan?”, we ask a more powerful question: “What if?”We explore how simple, practical scenario planning can help pharma supply chains prepare for the unexpected. From export restrictions and supplier failures to regulatory changes or a sudden surge in demand when a new use for a drug is approved earlier than planned.You’ll hear how to:Work with one time horizon and just a few focused scenariosIdentify where service, inventory, or capacity would break firstDefine “no-regret moves” that...
  • Leading in the BANI Decade — How Supply Chains Evolve When Leaders Do
    Leading in the BANI Decade — How Supply Chains Evolve When Leaders Do 24.11.2025 4m
    In this final episode of the BANI mini-series on Supply Chain 360, we shift the focus from systems to the people who run them: leaders.We revisit what it means to operate in a world that is brittle, anxious, nonlinear, and incomprehensible, and explore why supply chains only become truly viable when leadership mindsets evolve. This episode looks at how the best leaders move from control to composure, from rigid plans to adaptive thinking, and from managing risk to learning from it.We discuss the leadership behaviors that enable Complexity, Orchestration, Risk, and Enablement to work in practic...
  • White Swans in Plain Sight — Europe’s Industrial Migration and What It Means for Pharma
    White Swans in Plain Sight — Europe’s Industrial Migration and What It Means for Pharma 17.11.2025 5m
    In this episode of Supply Chain 360, part of the BANI mini-series, we explore a major shift that isn’t a sudden shock or black-swan event, but a white swan: a visible, predictable transformation that’s already reshaping Europe’s industrial landscape.Recent data shows that around 70% of energy-intensive companies are moving investments out of Germany, driven by rising energy costs, CO₂ pricing, political uncertainty, and slowing demand. This includes global players like ArcelorMittal, redirecting low-carbon steel projects to France, and German-based Schott AG, increasingly shifting its specialt...
  • Enablement — Empowering People and Systems to Adapt Faster than Disruption
    Enablement — Empowering People and Systems to Adapt Faster than Disruption 10.11.2025 4m
    In this episode of Supply Chain 360, part of the ongoing BANI mini-series, we explore the fourth and final CORE pillar: Enablement - the force that turns strategy into motion.In a world that’s brittle, anxious, nonlinear, and incomprehensible, enablement is what transforms information into action. It’s not just about tools or training, it’s about trust, confidence, and culture. When people are empowered with data they can use, systems they can trust, and the freedom to act within clear boundaries, agility becomes real.We look at how pharma supply chains can close the gap between knowing and do...
  • Risk — Intelligence Over Insurance in Pharma Supply Chains
    Risk — Intelligence Over Insurance in Pharma Supply Chains 03.11.2025 4m
    In this episode of Supply Chain 360, part of our BANI mini-series, we unpack the third CORE pillar: Risk. In a world that’s brittle, anxious, nonlinear, and incomprehensible, traditional “risk management” as a checklist or insurance policy isn’t enough. Today’s disruptions, cyber events, trade shifts, API shortages, extreme weather, don’t arrive one at a time; they overlap, cascade, and amplify.We reframe risk as intelligence: something to sense early, understand quickly, and act on decisively. You’ll hear how pharma leaders can build real-time visibility across suppliers and lanes, turn incid...
  • Orchestration — Turning Chaos into Coordination in Pharma Supply Chains
    Orchestration — Turning Chaos into Coordination in Pharma Supply Chains 27.10.2025 5m
    In this episode of Supply Chain 360, part of the ongoing BANI mini-series, we explore the second CORE pillar: Orchestration — the art of turning complexity into coordination.Pharma supply chains are filled with hundreds of moving parts — suppliers, regulators, logistics partners, and manufacturers — all operating on their own timelines. True orchestration is about creating alignment along the entire value chain, bringing people, processes, and systems into rhythm even when the world feels out of tune.We’ll discuss why visibility is the “baton” for modern leaders, how collaboration beats contro...
  • Complexity — The Invisible Web of Modern Pharma Supply Chains
    Complexity — The Invisible Web of Modern Pharma Supply Chains 22.10.2025 3m
    In this episode of Supply Chain 360, part of the ongoing BANI mini-series, we dive into the first CORE pillar: Complexity. Pharma supply chains aren’t simple, linear systems, they’re intricate networks of suppliers, regulators, manufacturers, and logistics partners, all bound together by interdependence and risk. The more we’ve optimized for efficiency, the more brittle those networks have become.This episode explores how leaders can move from fighting complexity to understanding and orchestrating it. We discuss visibility, systems thinking, and the power of mapping interdependencies to antici...
  • Beyond Resilience — The Age of Viability in Pharma Supply Chains
    Beyond Resilience — The Age of Viability in Pharma Supply Chains 14.10.2025 3m
    In this episode of Supply Chain 360, we continue our BANI mini-series — exploring how to lead and build in a world that’s brittle, anxious, nonlinear, and incomprehensible.For years, resilience was the ultimate goal in supply-chain management. But in today’s constant state of disruption, bouncing back isn’t enough. It’s time to move toward viability — the ability to adapt, evolve, and stay relevant no matter what happens next.We unpack what “viability” really means for pharma supply chains, why traditional recovery models are falling short, and how the next decade belongs to companies that des...
  • Navigating Pharma Supply Chains through a BANI World
    Navigating Pharma Supply Chains through a BANI World 13.10.2025 5m
    This kickoff to my BANI mini‑series unpacks how brittle, anxious, non‑linear and incomprehensible dynamics are reshaping pharma supply chains. We discuss real‑world brittleness: a 7.4‑magnitude earthquake in Japan that halted chip production and ground Detroit’s auto assembly, and a software update that locked up millions of computers and grounded. We examine how U.S. tariffs on Chinese imports have pushed logistics costs up 10–15 % for 60 % of companies and how Houthi attacks have closed the Red Sea shipping route, forcing vessels to detour around the Cape of Good Hope, adding up to 12 days a...
  • Responsible AI: Are we losing the Human in the Process?
    Responsible AI: Are we losing the Human in the Process? 13.10.2025 2m
    In this episode, I reflect on the growing trend of AI being used to cut jobs, often without a clear plan for reskilling or redeployment. Triggered by a recent New York Times article mentioning layoffs at companies like Microsoft and Recruit Holdings, I question whether we’re losing the human in the process. AI isn’t the problem. It’s how we choose to implement it that matters. Here is the link to my whitepaper on this topic: The Social Impact of AI: Rethinking Corporate Responsibility in the Age of Intelligent Transformation | LinkedIn
  • Talent Management - A balanced approach to Leadership and Followership
    Talent Management - A balanced approach to Leadership and Followership 13.10.2025 6m
    Welcome to this special episode of my podcast, where I explore the critical aspects of Talent Management—not just as a process of developing leaders but as a balanced framework that equally emphasizes followership development. Using insights from various scholarly and professional sources, I aim to reshape how organizations think about managing their most vital asset: People.
  • Artificial Intelligence (AI) in Pharmaceutical Manufacturing
    Artificial Intelligence (AI) in Pharmaceutical Manufacturing 13.10.2025 5m
    Today's episode focuses on the role of AI in Pharmaceutical Manufacturing, specifically how it is powering personalized medicine. We will explore AI's impact today and what the future looks like by 2030, with technologies like digital twins driving efficiency and precision in drug development.
  • Supply Chain Quo Vadis - How identified challenges become opportunities - or not?
    Supply Chain Quo Vadis - How identified challenges become opportunities - or not? 13.10.2025 6m
    In this episode we will dive into how identified challenges in supply chain management become opportunities - or maybe not?Curious? Tune in and find out.

Popular in

The podcast also appears in the podcast charts of these countries.